πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

8 results for β€œexenatide” Clear

  1. EXENATIDE

    Disc Medicine

    Gestational diabetes

    phase 2 small molecule active

    1 trial

  2. EXENATIDE

    Disc Medicine

    paragangliomas

    phase 2 small molecule active

    1 trial

  3. EXENATIDE , VERAPAMIL

    Disc Medicine

    type 1 diabetes mellitus

    phase 2 small molecule active

    1 trial

  4. Exenatide 3.5ΞΌg/mL solution for subcutaneous injection, Potassium canrenoate 5mg/mL solution for intravenous injection, Amodiaquine+Glibenclamide (10mg+0.1mg) /5mL oral suspension, Amodiaquine 2mg/mL solution for intravenous injection, Potassium canrenoate 25mg/5mL oral suspension

    Pharma Mar S.A.

    Acute Ischemic Stroke

    phase 2 small molecule active

    1 trial

  5. Exenatide Circular RNA-Lipid Nanoparticle Injection（ CR059οΌ‰οΌ‰

    First Tracks Biotherapeutics

    T2DM

    phase 1 small molecule active

    1 trial

  6. Exenatide

    First Tracks Biotherapeutics

    Type 2 Diabetes

    approved small molecule active

    1 trial

  7. Exenatide

    China SXT Pharmaceuticals

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  8. insulin lispro injection, exenatide injection

    First Tracks Biotherapeutics

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources